153 related articles for article (PubMed ID: 16807314)
1. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
3. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
5. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation.
Reed K; Poulin ML; Yan L; Parissenti AM
Anal Biochem; 2010 Feb; 397(1):96-106. PubMed ID: 19835834
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.
Ikoma D; Ichikawa D; Ueda Y; Tani N; Tomita H; Sai S; Kikuchi S; Fujiwara H; Otsuji E; Yamagishi H
Anticancer Res; 2007; 27(1B):535-9. PubMed ID: 17348438
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative molecular margin analysis in head and neck cancer.
Goldenberg D; Harden S; Masayesva BG; Ha P; Benoit N; Westra WH; Koch WM; Sidransky D; Califano JA
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):39-44. PubMed ID: 14732766
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
[TBL] [Abstract][Full Text] [Related]
11. Detection of p16 promoter methylation in the serum of oral cancer patients.
Nakahara Y; Shintani S; Mihara M; Hino S; Hamakawa H
Int J Oral Maxillofac Surg; 2006 Apr; 35(4):362-5. PubMed ID: 16298513
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction.
Lo YM; Wong IH; Zhang J; Tein MS; Ng MH; Hjelm NM
Cancer Res; 1999 Aug; 59(16):3899-903. PubMed ID: 10463578
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
14. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
16. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
[TBL] [Abstract][Full Text] [Related]
18. Saliva collection methods for DNA biomarker analysis in oral cancer patients.
Matthews AM; Kaur H; Dodd M; D'Souza J; Liloglou T; Shaw RJ; Risk JM
Br J Oral Maxillofac Surg; 2013 Jul; 51(5):394-8. PubMed ID: 23068125
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
Fukuoka T; Hibi K; Nakao A
Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
